Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Connective Tissue Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00647270
What this trial is testing

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Who this might be right for
Rheumatoid Arthritis
Abbott 420
Early research (Phase 1)Looking for participantsNCT06926283
What this trial is testing

DXC008 in Patients With Prostate Cancer and Other Solid Tumors

Who this might be right for
Prostate CancerOther Solid TumorsEwing Sarcoma
Hangzhou DAC Biotechnology Co., Ltd. 110
Testing effectiveness (Phase 2)Looking for participantsNCT06369831
What this trial is testing

HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011

Who this might be right for
Metastatic Breast CancerMetastatic Solid Cancer
Abscint NV/SA 60
Testing effectiveness (Phase 2)Ended earlyNCT01624090
What this trial is testing

Mithramycin for Lung, Esophagus, and Other Chest Cancers

Who this might be right for
Lung CancerEsophageal CancerMesothelioma+2 more
National Cancer Institute (NCI) 16
Not applicableLooking for participantsNCT01441089
What this trial is testing

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Who this might be right for
Prostate CancerBreast CancerLung Cancer+2 more
National Cancer Institute (NCI) 1,100
Early research (Phase 1)Study completedNCT02475213
What this trial is testing

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

Who this might be right for
MelanomaHead and Neck CancerNon Small Cell Lung Cancer+1 more
MacroGenics 146
Testing effectiveness (Phase 2)Study completedNCT00831844
What this trial is testing

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more
National Cancer Institute (NCI) 116
Not applicableLooking for participantsNCT03300830
What this trial is testing

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

Who this might be right for
Human Immunodeficiency VirusCastleman's DiseaseKaposi's Sarcoma+1 more
National Cancer Institute (NCI) 280
Not applicableEnrolling By InvitationNCT03254667
What this trial is testing

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 3,500
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Early research (Phase 1)Active Not RecruitingNCT03162627
What this trial is testing

Selumetinib and Olaparib in Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital Organs+2 more
M.D. Anderson Cancer Center 90
Large-scale testing (Phase 3)Study completedNCT00069641
What this trial is testing

Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)

Who this might be right for
Mucopolysaccharidosis II
Shire 96
Testing effectiveness (Phase 2)WithdrawnNCT05561491
What this trial is testing

ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Who this might be right for
Melanoma
Targovax Oy
Testing effectiveness (Phase 2)Study completedNCT04071574
What this trial is testing

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Who this might be right for
Female InfertilityFemale Infertility Due to Ovulatory DisorderPremature Ovarian Failure+14 more
Lebanese University 200
Not applicableStudy completedNCT00248911
What this trial is testing

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Who this might be right for
Breast CancersGynecologic Cancer
Weill Medical College of Cornell University 94
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Not applicableLooking for participantsNCT06103669
What this trial is testing

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Who this might be right for
Breast CancerOligoprogressiveHead and Neck Cancer+2 more
University of California, Davis 250
Not applicableStudy completedNCT03270241
What this trial is testing

Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy

Who this might be right for
VitiligoDermatology/Skin - Other
Johns Hopkins University 10
Early research (Phase 1)Ended earlyNCT03272464
What this trial is testing

INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.

Who this might be right for
Melanoma
Massachusetts General Hospital 1
Next Page